Keppra and Lipoic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra and Lipoic acid. Common interactions include diabetic ketoacidosis among females and depression among males.

The phase IV clinical study analyzes what interactions people who take Keppra and Lipoic acid have. It is created by eHealthMe based on reports of 36 people who take Keppra and Lipoic acid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

36 people who take Keppra and Lipoic acid together, and have interactions are studied.


What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 61,795 Keppra users for its effectiveness, alternative drugs and more.

What is Lipoic acid?

Lipoic acid has active ingredients of alpha - lipoic acid. It is often used in peripheral neuropathy. eHealthMe is studying from 4,102 Lipoic acid users for its effectiveness, alternative drugs and more.

Number of Keppra and Lipoic acid reports submitted per year:

Keppra and Lipoic acid drug interactions.

Common Keppra and Lipoic Acid drug interactions by gender *:

female:

  1. Diabetic ketoacidosis
  2. Diabetic neuropathy
  3. Diabetic retinopathy
  4. Dysmenorrhoea
  5. Energy increased
  6. Erythema
  7. Hallucination
  8. Hospitalisation
  9. Hypoaesthesia
  10. Hypoglycaemia

male:

  1. Depression
  2. Anxiety
  3. Fatigue
  4. Gait disturbance
  5. Gastrointestinal haemorrhage
  6. Haematuria
  7. Hallucination
  8. Hot flush
  9. Hyperlipidaemia
  10. Hypertension

Common Keppra and Lipoic Acid drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hypoaesthesia
  2. Mood swings
  3. Restless legs syndrome

30-39:

n/a

40-49:

  1. Depression
  2. Hyperlipidaemia
  3. Hypertension
  4. Migraine
  5. Type 2 diabetes mellitus

50-59:

  1. Fall
  2. Nausea
  3. Tremor
  4. Headache
  5. Vomiting
  6. Back pain
  7. Balance disorder
  8. Contusion
  9. Diarrhoea
  10. Discomfort

60+:

  1. Anxiety
  2. Balance disorder
  3. Fatigue
  4. Gait disturbance
  5. Gastrointestinal haemorrhage
  6. Haematuria
  7. Hallucination
  8. Hot flush
  9. Hypoaesthesia
  10. Hypokalaemia

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 38.89%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 27.78%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 11.11%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 11.11%
  5. Pain: 3 people, 8.33%
  6. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 5.56%
  7. Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 5.56%
  8. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 5.56%
  9. Migraine (headache): 2 people, 5.56%
  10. Constipation: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Lipoic acid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Keppra and Lipoic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Keppra interactions:

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lipoic acid interactions:

Browse all interactions between Lipoic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and alpha - lipoic acid (the active ingredients of Keppra and Lipoic acid, respectively), and Keppra and Lipoic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Keppra and Lipoic acid.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: